U.S. Home Infusion Therapy Market Size By Product (Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors), By Application (Anti-infective, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals), Industry Analysis Report, Regional Outlook, Application Potential & Forecast, 2018 – 2024

Published Date: Jun 2018  |  Report ID: GMI2641  |  Authors: Sumant Ugalmugale

Report Format: PDF   |   Pages: 170   |   Base Year: 2017

Summary Table of Contents Industry Coverage Methodology

Industry Trends

U.S. Home Infusion Therapy Market size was valued around USD 7 billion in 2017 and is expected to witness more than 10% CAGR from 2018 to 2024.

East North Central Home Infusion Therapy Market, By Product, 2013 – 2024 (USD Billion)

Get more details on this report - Request Free Sample PDF

Technological advancements such as automations in the medical devices have fuelled growth of U.S. home infusion therapy market. These technological advancements enable improvisations in the existing medical products thereby enhancing user experience. For instance, the infusion pumps used in the home infusion therapy have been modified into smart infusion pumps to reduce dosage errors that may otherwise occur while using conventional infusion pumps. Government initiatives such as increase R&D funding to facilitate modifications in infusion therapy products will propel business growth.

Growing geriatric population is one of the major industry growth drivers. Statistics presented by World Atlas supports the fact that by 2060 elderly population in the U.S. will be more than 98 million. Geriatric population is more prone to infections due to poor immunity that increases the rate of infections supporting the U.S. home infusion therapy market growth. More preference is given to the home infusion therapy by the elderly based population due to ease and convenience.

Rising prevalence of chronic diseases such as cancer, diabetes and COPD have increased the demand for home infusion therapies market. Continuous monitoring and treatment of chronic diseases will boost market growth. However, unfavourable reimbursement scenario will restrict the market growth over the forecast period.

U.S. Home Infusion Therapy Market Report Coverage
Report Coverage Details
Base Year: 2017 Market Size in 2017: 7 Billion (USD)
Historical Data for: 2013 to 2017 Forecast Period: 2018 to 2024
Forecast Period 2018 to 2024 CAGR: 10% 2024 Value Projection: 13.5 Billion (USD)
Pages: 170 Tables, Charts & Figures: 163
Geographies covered: East North Central {Illinois, Indiana, Michigan, Ohio, Wisconsin}, West South Central {Arkansas, Louisiana, Oklahoma, Texas},South Atlantic {Delaware, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia, Washington, D.C}, North East {Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont, New Jersey, New York, Pennsylvania}, East South Central {Alabama, Kentucky, Mississippi, Tennessee}, West North Central {Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota}, Pacific Central {Alaska, California, Hawaii, Oregon, Washington}, Mountain States {Arizona, Colorado, Utah, Nevada, New Mexico, Idaho, Montana, Wyoming}
Segments covered: Product, Application and Region
Companies covered (11): Amsino International, Inc, Baxter International, Inc, B.Braun Melsungen AG, Becton Dickinson, Caesarea Medical Electronics, Fresenius Kabi, Halyard Health, Inc, ICU Medical Inc, Moog Inc, Smiths Medical, Terumo Corporation
Growth Drivers:
  • Growing hospital acquired infections
  • Rising prevalence of chronic diseases
  • Advancements in technology
  • Growing geriatric population
  • Presence of homecare facilities
Pitfalls & Challenges:
  • Dearth of reimbursement

Request 15% Free Customization on this Report

U.S. Home Infusion Therapy Market, By Product

Infusion pump segment held around 51% in market share in 2017 and is estimated to grow at a CAGR of 9.8% over the forecast timeline. Growth is attributed to modifications incorporated in infusion pumps that have reduced errors while administering the fluids in patient’s body. Rising prevalence of diseases and surgical procedures have escalated demand for infusion pumps.

Needleless connectors segment will grow at a CAGR of 10.5% over the forecast period due to growing demand for hydration therapies and rising prevalence of diseases such as malaria, dengue and others that requires continuous supply of fluids. Patients suffering from chronic conditions require continuous supply of medical accessories such as needleless connectors thereby will accelerate business growth over the forecast timeframe.

U.S. Home Infusion Therapy Market, By Application

Anti-infectives accounted for over 27.5% market share in 2017 and is anticipated to continue dominating the industry over the upcoming years. Growing rates of bacterial, viral and other infections coupled with rising rates of hospital acquired infections escalate the demand for anti-infectives therapy enhancing overall industry growth.

Parenteral nutrition segment will witness lucrative growth over the coming years owing to increasing demand for home infusion therapies. Around 40,000 people in U.S. receive home parenteral nutrition safely through variety of catheters. The therapeutic benefits as well as treatment against poor functioning of gastro-intestinal tract disorders through parenteral nutrition should propel its demand over the forecast timeframe.

U.S. Home Infusion Therapy Market, By Region

South Atlantic home infusion therapy market will grow owing to rising number of home infusion therapy pharmacies in the region. These pharmacies treat the patients that are suffer from chronic as well as acute diseases. Moreover, increasing average household income of population enhancing the investment capacity of population in healthcare services will positively impact adoption of home infusion therapy.

Pacific Central home infusion therapy market is anticipated to grow at 11.7% CAGR over forecast period due increasing number of government initiatives that have resolved the affordability issues of geriatric population. Such initiative has proven beneficial for geriatric population for availing the home infusion therapies thereby fuelling overall industry growth.

Competitive Market Share

Major industry players operating in U.S. home infusion therapy market are Amsino International, Baxter International, B.Braun, Becton Dickinson, Caesarea Medical Electronics, Fresenius Kabi, Halyard health, ICU Medical, Moog, Smiths Medical, and Terumo Corporation. Strategic initiatives undertaken by key industry players include merger, acquisitions and new product launch to assist in gaining competitive advantage as well as achieve sustainable profits.

For instance, in February 2017, ICU medical Inc. completed the acquisition of Pfizer’s Hospira infusion systems business. The inclusion of Hospira’s IV pumps, devices and solutions to ICU Medical’s current portfolio will aid in revenue generation of the company as well as diversification of product portfolio.

U.S. Home Infusion Therapy Industry Background

The key industry players have been undertaking numerous strategic initiatives to improvise their product offerings to increase market share as well as strengthen product portfolio. Modifications are being made by integrating advanced technology into the medical devices that are being used in the home infusion therapy to reduce errors, thereby increasing adoption rate of the device.

Medical insurance companies such as Medicare and Medicaid are focusing on improving the reimbursement structure for home infusion therapy will positively impact industry growth. Furthermore, improving economic conditions in emerging regions of the U.S. have escalated the overall adoption of home infusion therapy in the country.

Buy NowImmediate delivery available

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X